Arcadia Biosciences
RKDA
18 hedge funds and large institutions have $147K invested in Arcadia Biosciences in 2026 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 7 closing their positions.
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
13% more funds holding
Funds holding: 16 → 18 (+2)
6.66% less ownership
Funds ownership: 16.99% → 10.33% (-6.7%)
70% less capital invested
Capital invested by funds: $482K → $147K (-$336K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$91.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$24.6K |
| 3 |
VF
Virtu Financial
New York
|
+$22.6K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$16K |
| 5 |
SG
StoneX Group
New York
|
+$14.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$220K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$158K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17.4K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$16.2K |
| 5 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
-$6.06K |
RKDA Hedge Fund Activity: Q2 2026 in Review
18 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q2 2026, worth a combined $147K — down 70% from $482K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new RKDA positions and 7 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $91.5K. The largest seller was Armistice Capital, exiting entirely with an estimated $220K sold.
- 18 institutional investors held Arcadia Biosciences (RKDA) as of Q2 2026, up from 16 in Q1 2026.
- Funds reported $147K of Arcadia Biosciences stock for Q2 2026, down 70% quarter-over-quarter.
- 9 funds opened new Arcadia Biosciences positions in Q2 2026 and 7 closed out, a net change of +2 holders.
- The largest Arcadia Biosciences buyer in Q2 2026 was HRT Financial, an estimated $91.5K added.
- The largest Arcadia Biosciences seller in Q2 2026 was Armistice Capital, an estimated $220K sold.
Based on aggregated 13F filings for Q2 2026.